|
Tuesday 10th November 2020 |
Text too small? |
NZX Regulation advises that, at the request of the company, Abano Healthcare Group Limited (NZX: ABA ) ordinary shares remain in a halt.
The trading halt has been extended to allow for completion of an addendum report by Calibre Partners, the Independent Adviser under the scheme of arrangement proposal to reflect updated financial information provided by ABA, and to allow for that report to be considered by the parties to the scheme of arrangement and released.
The trading halt will remain in place until the earlier of:
• An announcement by ABA in relation to the updated information; or
• Market open on Thursday, 12 November 2020.
See the links below for more details:
ABA – Trading Halt of Securities
Source: Abano Healthcare Group Limited
No comments yet
June 2nd Morning Report
IKE - FY26 Financial Results
Chorus submits 2025 fibre regulatory report
SPG - FY26 Annual Results
PYS - PaySauce FY26 Full Year Result and Annual Report
IFT - Infratil Full Year Results for the year ended 31 March 2026
May 27th Morning Report
RYM - FY26 marks significant year of progress
FPH reports strong revenue and profit growth for FY26
IFT - Infratil Full Year Results for the year ended 31 March 2026